A global Phase 2 study of PTG-200 in Crohn's disease
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2018
At a glance
- Drugs PTG 200 (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 07 Aug 2018 According to a Protagonist media release, Protagonist expects a U.S. IND filing by its partner Janssen Biotech in the fourth quarter of 2018.
- 13 Mar 2018 New trial record
- 07 Mar 2018 According to a Protagonist media release, company plans to file a U.S. IND and initiate this study in the second half of 2018.